Literature DB >> 15601600

Amygdala responses to human faces in obsessive-compulsive disorder.

Paul A Cannistraro1, Christopher I Wright, Michelle M Wedig, Brian Martis, Lisa M Shin, Sabine Wilhelm, Scott L Rauch.   

Abstract

BACKGROUND: To assess the amygdala response to emotional faces in obsessive-compulsive disorder (OCD) using functional magnetic resonance imaging (fMRI).
METHODS: Ten subjects with current OCD and 10 healthy control subjects underwent fMRI, during which they viewed pictures of fearful, happy, and neutral human faces, as well as a fixation cross.
RESULTS: Across both groups, there was significant activation in left and right amygdala for the fearful versus neutral faces contrast. Data extracted from these functionally defined regions of interest indicated that OCD subjects exhibited a weaker response than control subjects bilaterally across all face conditions versus fixation. No group-by-face condition interactions were observed.
CONCLUSIONS: Contrary to findings in other anxiety disorders, there was no observed increase in amygdala responsivity to fearful versus neutral human faces in OCD as compared with healthy control subjects. Moreover, across all face conditions, amygdala responsivity was attenuated in OCD subjects relative to control subjects. Therefore, the present findings are consistent with abnormal amygdala function in OCD and are of a character that may distinguish OCD from other anxiety disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15601600     DOI: 10.1016/j.biopsych.2004.09.029

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  28 in total

Review 1.  Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways.

Authors:  Mohammed R Milad; Scott L Rauch
Journal:  Trends Cogn Sci       Date:  2011-12-02       Impact factor: 20.229

2.  Anatomic alterations across amygdala subnuclei in medication-free patients with obsessive-compulsive disorder.

Authors:  Lianqing Zhang; Xinyu Hu; Lu Lu; Bin Li; Xiaoxiao Hu; Xuan Bu; Hailong Li; Shi Tang; Yingxue Gao; Yanchun Yang; John A Sweeney; Qiyong Gong; Xiaoqi Huang
Journal:  J Psychiatry Neurosci       Date:  2020-09-01       Impact factor: 6.186

Review 3.  Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studies.

Authors:  Paolo Fusar-Poli; Anna Placentino; Francesco Carletti; Paola Landi; Paul Allen; Simon Surguladze; Francesco Benedetti; Marta Abbamonte; Roberto Gasparotti; Francesco Barale; Jorge Perez; Philip McGuire; Pierluigi Politi
Journal:  J Psychiatry Neurosci       Date:  2009-11       Impact factor: 6.186

Review 4.  The neurocircuitry of fear, stress, and anxiety disorders.

Authors:  Lisa M Shin; Israel Liberzon
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

5.  Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia.

Authors:  Amit Etkin; Tor D Wager
Journal:  Am J Psychiatry       Date:  2007-10       Impact factor: 18.112

6.  The neurotensin-1 receptor agonist PD149163 blocks fear-potentiated startle.

Authors:  Paul D Shilling; David Feifel
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

Review 7.  Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited.

Authors:  Lara Menzies; Samuel R Chamberlain; Angela R Laird; Sarah M Thelen; Barbara J Sahakian; Ed T Bullmore
Journal:  Neurosci Biobehav Rev       Date:  2007-10-17       Impact factor: 8.989

Review 8.  The role of neuroimaging for the diagnosis and treatment of anxiety disorders.

Authors:  Martin P Paulus
Journal:  Depress Anxiety       Date:  2008       Impact factor: 6.505

Review 9.  α2-containing GABA(A) receptors: a target for the development of novel treatment strategies for CNS disorders.

Authors:  Elif Engin; Jing Liu; Uwe Rudolph
Journal:  Pharmacol Ther       Date:  2012-08-18       Impact factor: 12.310

10.  Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder.

Authors:  Jonathan T Ting; Guoping Feng
Journal:  Curr Chem Genomics       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.